Teva, Purdue and Pfizer line up data for new round of powerful painkillers

Zogenix ($ZGNX) is facing some staunch opposition to its powerful new pain drug, Zohydro. Soon it could be facing some serious competition as well. Teva Pharmaceutical Industries ($TEVA), Purdue Pharmaceuticals and Pfizer ($PFE) are all touting new data on powerful painkillers they are developing. Report

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.

Roche got a two pieces of good Hemlibra news early this week—and what's good for Hemlibra must be good for Roche.